A number of factors such as the growing prevalence of SSIs, rising elderly population, and increasing volume of surgical procedures will help the surgical site infection market exhibit considerable growth in the coming years. Moreover, the rapid development of technologically advanced products in the medical sector and the implementation of favorable government regulations for the healthcare system will also drive the demand for SSI products globally. In addition, the mounting healthcare expenditure will also contribute to the market growth.
One of the prominent growth drivers of the market is the increasing volume of surgical procedures worldwide. According to the OECD, 540,947 surgeries, 411,668 surgeries, 882,284 surgeries, 923,267 surgeries, 578,884 surgeries, 450,247 surgeries, and 98,970 surgeries were performed in the U.K., Canada, Germany, France, Italy, Spain, and Mexico, respectively, in 2019. A surge in surgical procedures, owing to the rising burden of road accidents and chronic diseases, will result in the high volume adoption of SSI products globally.
The antibiotic prophylaxis products category generated the highest revenue in the surgical site infection industry in the preceding years, under the product segment. These products are being adopted by healthcare facilities to prevent contamination and infection during treatment. The increasing use of antibiotic prophylaxis products as a common preventive measure in healthcare units will help this category retain its dominance in the upcoming years as well. However, the antiseptic and disinfectant product category will witness the fastest growth in the coming years.
In recent years, players in the surgical site infection industry have opted for mergers and acquisitions to gain a competitive edge. For example, in June 2016, B Barun Medical acquired Dismed Criticare (Pty.) Ltd. and Dismed Pharmaceutical (Pty.) Ltd. to provide effective medical care solutions, such as hand sanitizer and intravenous fluid of Dismed, to the people of South Africa. Other players undertaking such strategic measures include 3M Company, Covalon Technologies Ltd., HARTMANN GROUP, and Becton, Dickinson and Company.
According to P&S Intelligence, North America accounted for the largest share of the surgical site infection market in the last few years. The dominance of this region is attributed to the presence of a well-developed healthcare sector and prominent SSI product manufacturers in the region. Moreover, the surging geriatric population, growing incidence of surgical procedures, and soaring public awareness about SSIs will also fuel the market growth in Canada and the U.S. As per the 2020 Profile of Older Americans, the population of women and men aged more than 65 years in the U.S. was 30 million and 24.1 million, respectively, in 2019.
Whereas, the APAC surgical site infection market is expected to demonstrate the fastest growth in the upcoming years. This will be on account of the soaring geriatric population, rising incidence of SSIs, improving healthcare infrastructure, and increasing use of technologically advanced products in the region. By 2050, 1 in 4 people in the region will be more than 60 years of age, according to the UNFPA. The organization also forecasts that the population of this age pool in APAC will reach around 1.3 billion by 2050.
Leave a Reply